As a novel GLP-1 analogue, liraglutide had been used to treat diabetes since 2009 and was also reported to have the effect of improving glycemic control in diabetic mice [20], which decreased the occurrence of hyperglycemia. The gene discussed is GCG; the disease is Hyperglycemia.